Pathway Summary for MTC7

Overview

MTC7 is not yet placed in a defined pathway. Its UniProt entry describes Mtc7 as a small predicted multi-pass membrane protein with two transmembrane helices, and the local bioinformatics analysis supports the same broad topology: two N-terminal hydrophobic helices followed by a basic, likely disordered C-terminal region [file:yeast/MTC7/MTC7-bioinformatics/RESULTS.md].

The telomere-capping name comes from a genome-wide cdc13-1 genetic-interaction screen that identified many deletions with subtle effects on the growth of telomere-uncapping strains [PMID:18845848]. That screen is useful evidence that MTC7 is worth testing in telomere biology, but it does not establish Mtc7 as a structural capping factor, a CST-complex component, a telomerase regulator, or a direct telomere-localized protein.

Telomere Hypothesis

Addinall et al. used the yeast deletion collection to search for genes that suppress, enhance, or modify the reversibility of cdc13-1 temperature sensitivity. The screen recovered expected DNA damage checkpoint, telomerase, and nonsense-mediated decay genes and also a larger set of previously uncharacterized genes that the authors named RTC or MTC [PMID:18845848].

Two constraints keep the MTC7 model unresolved:

The cdc13-1 result is a high-throughput genetic phenotype. It does not distinguish direct chromosome-end capping from indirect changes in growth, stress tolerance, proteostasis, membrane biology, or the cellular response to uncapped telomeres.
An earlier genome-wide telomere-length screen flagged YEL033W but then showed that its short-telomere phenotype did not cosegregate with the YEL033W deletion marker. Askree et al. concluded instead that the deletion segregated with very slow growth while the short telomeres segregated with a suppressor mutation, leaving only an indirect candidate interaction with an unidentified telomere-function gene [PMID:15161972].

Membrane Protein Features

Mtc7 has two predicted transmembrane helices near its N terminus and a lysine-rich C-terminal tail [file:yeast/MTC7/MTC7-bioinformatics/RESULTS.md]. These features support the current membrane cellular-component annotation, but they do not explain the cdc13-1 genetic interaction. The charged tail could mediate protein, lipid, or nucleic-acid contacts, and the membrane anchor could place Mtc7 at an endomembrane compartment; both ideas remain hypotheses until Mtc7 is localized and its interaction partners are identified.

Working Model

flowchart TD A["MTC7 deletion"] --> B["cdc13-1 modifier phenotype"] A --> C["Very slow growth?"] C --> D["Suppressor mutation?"] D -. "short telomeres in collection strain" .-> E["Indirect telomere effect?"] A --> F["Membrane biology?"] A --> G["Stress response?"] E -. "unproven" .-> B F -. "unknown mechanism" .-> B G -. "unknown mechanism" .-> B

Experiments Needed

The pathway question for MTC7 is still open. The most direct next tests are to localize endogenously tagged, functional Mtc7; compare telomere length and single-stranded telomeric DNA in freshly reconstructed mtc7 mutants; and identify physical interactors during ordinary growth and cdc13-1 telomere-uncapping stress.